NMN Reference

Plain English

What it is

NMN (nicotinamide mononucleotide) is a building block the body uses to make NAD+, a molecule that cells need for energy. It is sold as a dietary supplement, not an approved medicine. Its US status has flipped: the FDA first said it could not be sold as a supplement because it was being studied as a drug, then reversed that and said NMN is not blocked from the supplement market.

What people use it for

People take NMN hoping to raise their NAD+ levels for healthy aging, steady energy, and sharper thinking.

What the science shows

Small, short human studies show that taking NMN can raise NAD+ markers in the blood and is generally well tolerated. But clear proof that it slows aging, adds healthy years, or improves memory and thinking is still missing. Researchers say it is too early to know, because large, long studies have not been done.

The catch

NMN is sold without the testing an approved drug must pass, and there is no long-term safety record in healthy people. Its place on US supplement shelves has been disputed by the FDA, and the popular longevity and brain claims remain largely unproven.

Reference summary

Small human pilot trials report increased blood NAD+ markers and modest improvements in surrogate longevity markers. Long-term outcome data in healthy adults is absent.

Regulatory and posture

Categories

Nootropic, Longevity, Metabolic

Aliases

Nicotinamide mononucleotide, β-NMN

Evidence posture

human - Regulatory status as a dietary supplement is contested - FDA has indicated NMN is not a lawful dietary ingredient because it is being studied as a drug. Sold as a supplement despite the regulatory uncertainty. Long-term outcome data in healthy adults is absent.

Regulatory status

No FDA-approved NMN drug label. NDI status with FDA is contested - FDA has issued letters indicating NMN is not a lawful dietary ingredient because it is being studied as a drug. Sold as a dietary supplement despite the regulatory uncertainty.

Content review status

research reference